Structured evidence table for Magnesium Fatigue Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Magnesium Fatigue Randomized Trial | Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Magnesium Fatigue Randomized Trial | While both the quantity and the quality of sleep can be largely improved with relatively straightforward practices dictated by good sleep hygiene, emerging research suggests that dietary and supplementation protocols focused on certain foods, nutrients, and biochemical compounds with sleep-promoting properties can act as subsidiary sleep aids in complementing these behavioral changes. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Magnesium Fatigue Randomized Trial | The scope of this narrative review is to summarize the available evidence on the potential benefits of selected nutraceuticals in the context of circadian rhythm and sleep disturbances, namely melatonin, magnesium, omega-3 fatty acids, tart cherry juice, kiwifruit, apigenin, valerian root, L-theanine, glycine, ashwagandha, myoinositol, Rhodiola rosea, and phosphatidylserine. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Magnesium Fatigue Randomized Trial | Humans spend approximately one third of their life asleep but, as counterintuitive as it may sound, sleep is far from being a quiet state of inactivity. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Magnesium Fatigue Randomized Trial | It is defined as a persistent feeling of exhaustion, tiredness, and weakness that results in reduced mental and/or physical capacity. | 4 | Ramezani Elmira (2026) | Effects of B vitamins and magnesium on fatigue, disease activity and quality of life in inflammatory bowel disease |
| Magnesium Fatigue Randomized Trial | Factors such as increased disease activity, musculoskeletal pain, and fatigue contribute to this decline. | 4 | Ramezani Elmira (2026) | Effects of B vitamins and magnesium on fatigue, disease activity and quality of life in inflammatory bowel disease |
| Magnesium Fatigue Randomized Trial | 18 19 6 1 6 12 In addition, even with adequate nutritional intake, patients with IBD are at risk of developing vitamin and mineral deficiencies. | 4 | Ramezani Elmira (2026) | Effects of B vitamins and magnesium on fatigue, disease activity and quality of life in inflammatory bowel disease |
| Magnesium Fatigue Randomized Trial | 1 2 3 4 5 , Inflammatory bowel disease (IBD) comprises a group of chronic gastrointestinal disorders, primarily ulcerative colitis (UC) and Crohn’s disease (CD). | 4 | Ramezani Elmira (2026) | Effects of B vitamins and magnesium on fatigue, disease activity and quality of life in inflammatory bowel disease |
Source documents